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single-neuron and network-wide Arc/Arg3.1
responses
Nikita Rudinskiy1,2, Jonathan M Hawkes1,3, Susanne Wegmann1, Kishore V Kuchibhotla1,4, Alona Muzikansky5,
Rebecca A Betensky6, Tara L Spires-Jones1,7 and Bradley T Hyman1*Abstract
Intraneuronal neurofibrillary tangles (NFTs) – a characteristic pathological feature of Alzheimer’s and several other
neurodegenerative diseases – are considered a major target for drug development. Tangle load correlates well with
the severity of cognitive symptoms and mouse models of tauopathy are behaviorally impaired. However, there is
little evidence that NFTs directly impact physiological properties of host neurons. Here we used a transgenic mouse
model of tauopathy to study how advanced tau pathology in different brain regions affects activity-driven
expression of immediate-early gene Arc required for experience-dependent consolidation of long-term memories.
We demonstrate in vivo that visual cortex neurons with tangles are as likely to express comparable amounts of Arc in
response to structured visual stimulation as their neighbors without tangles. Probability of experience-dependent Arc
response was not affected by tau tangles in both visual cortex and hippocampal pyramidal neurons as determined
postmortem. Moreover, whole brain analysis showed that network-wide activity-driven Arc expression was not affected
by tau pathology in any of the brain regions, including brain areas with the highest tangle load. Our findings suggest
that intraneuronal NFTs do not affect signaling cascades leading to experience-dependent gene expression required
for long-term synaptic plasticity.
Keywords: Alzheimer’s disease, Tau, Neurofibrillary tangles, Arc, Neuronal activity, Activity-dependent expressionIntroduction
Intraneuronal neurofibrillary tangles (NFT) composed of
misfolded hyperphosphorylated tau proteins are one of
two stereotypical types of lesions present in the Alzhei-
mer’s brain (together with amyloid plaques) [1]. The ex-
tent of neurofibrillary pathology correlates well with
synaptic loss, neuronal loss, glial activation, and cogni-
tive decline [2] and tangles have long been considered a
primary therapeutic target in Alzheimer’s disease (AD).
Moreover, mutations in tau have been linked to neuro-
degeneration in several tauopathies, including FTDP-17
[3], and cerebral tau aggregates are present in many dis-
orders [4].* Correspondence: bhyman@partners.org
1Alzheimer’s Disease Research Laboratory, Department of Neurology,
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General
Hospital, Harvard Medical School, Charlestown 02129, MA, USA
Full list of author information is available at the end of the article
© 2014 Rudinskiy et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Despite the compelling proof for a role of misfolded
tau in neurodegenerative disease, little data directly test
the hypothesis that tangles, per se, impair neuronal func-
tion. In fact, there is no conclusive evidence for a mech-
anistic role of NFTs in dysregulation of nervous system,
either on a single-neuron or neuronal network level. We
hypothesized that the tangle pathology would disrupt in-
tegration of incoming information in individual neurons
with NFTs and that the brain networks most affected
by tangles would have impaired neuroplastic properties
when responding to sensory inputs in vivo. As a proxy
of experience-dependent network integration and
plasticity we used the activity-dependent transcription of
a memory-related immediate-early gene Arc. Activity-
driven expression of Arc is crucial for synaptic tagging and
remodeling in response to sensory and behavioral inputs
(reviewed in [5-9]) and is often used as a reporter of ex-
pression of neuroplasticity in excitatory neurons.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ology on the experience-driven Arc responses after a be-
haviorally relevant, well characterized visual stimulus
paradigm [10-13] to determine whether there are cell-
specific or network-wide plasticity deficits directly linked
to NFTs. We crossed the rTg4510 mice which express
P301L mutant form of human tau and develop advanced
tangle pathology [14], with a previously characterized
fluorescent reporter line of Arc transcription [10,15].
Using intravital fluorescent brain microscopy we found
that the presence of NFTs in visual cortex neurons did
not affect the amplitude of Arc responses to the stimula-
tion. Postmortem odds ratio analysis revealed that the
probability of Arc response in individual neurons in both
visual cortex and hippocampus is not affected by ex-
pression of mutant tau and/or presence of tau tangles.
Quantitative analysis of all brain regions with detect-
able neuronal Arc expression after visual stimulation
showed no differences in characteristics of network-wide
Arc responses between control and mutant mice, even in
the brain areas with the highest tangle load. Finally, reduc-
tion of brain-wide soluble human tau concentration by
suppression of mutant tau expression in the rTg4510 mice
did not affect Arc responses. These results indicate that
behavioral and physiological deficits observed in mice
expressing P301L mutant of human tau are not medi-
ated by alterations of post-synaptic pathways involved in
activity-dependent expression of immediate-early genes
such as Arc.
Results
Tau pathology does not affect the amplitude of
experience-driven Arc responses in the visual cortex
To study activity-induced Arc induction in vivo in the
brain of rTg4510 mice, we used Arc::dVenus reporter
and visual stimulation experimental paradigm similar to
our previous set of experiments with Arc::dVenus × APP/
PS1 strain [10]. The well characterized Arc::dVenus re-
porter line expresses destabilized bright yellow fluorescent
protein, dVenus, under the control of the Arc promoter
and allows quantification of activity-driven transcriptional
response of Arc gene in both living mice and postmor-
tem brain tissue [10,15]. Triple transgenic Arc::dVenus ×
CamKII::rtTA × tetO::Tau(P301L) (Arc::dVenus × rTg4510)
mice of tangle-bearing age (11–12 months old) and litter-
mate Arc::dVenus × CamKII::rtTA controls were housed in
light-proof dark enclosures for 60 hours prior to being
exposed for 1 hour to structured visual stimulation in
a glass cylinder with alternating black and white stripes
illuminated from the outside (Figure 1a). This type of vis-
ual stimulation induces robust expression of Arc::dVenus
in, among other brain areas, the anteromedial aspect of
extrastriate visual cortex reaching a maximum in roughly
6 hours (Figure 1b, also see [10]). After the stimulation,the mice were returned to their home cages and placed
into the dark enclosures for 5 hours. At the end of the
second light deprivation period mice were anesthetized,
implanted with a cranial window over the right visual cor-
tex and imaged with a 2-photon microscope (Figure 1a).
First, the mice were imaged using 860 nm excitation laser
to allow optimal simultaneous detection of dVenus signal
(Figure 1b) and Texas Red-conjugated dextrans which
were injected intravenously to create a reference fluores-
cent angiogram. Image segmentation and quantification of
dVenus signal in individual neurons showed no difference
in dVenus expression level distributions between rTg4510
mice and littermate controls (P = 0.27, Figure 1c) and
the shape of the histograms was similar to the data from
Arc::dVenus controls in [10]. After dVenus imaging, the
blood–brain barrier-permeable Congo Red derivative dye
methoxy-X04 [16] mixed with Texas Red dextrans was
injected intravenously. Methoxy-X04 has previously been
shown to efficiently label NFTs in post-mortem brain
tissue from human AD subjects [16] and transgenic mice
expressing mutant tau [17]. After a short incubation to
allow drug diffusion in the brain, the same visual cortex
area was re-imaged with 800 nm excitation to visualize
methoxy-X04-labeled NFTs and the angiogram (Figure 1d).
Precise overlay of dVenus and methoxy-X04 images of
the same cortical areas allowed us to determine whether
individual dVenus-positive neurons had tangles or not.
We found no significant difference in dVenus expression
levels, representing the amplitude of Arc response, be-
tween tangle-free and tangle-bearing neurons (P = 0.083,
Figure 1e).
NFTs do not change the probability of Arc response in
the host neurons
Having found that tangles do not influence the amplitude
of Arc responses in the active neurons, we next asked
whether they might affect the overall probability of re-
sponse. Following in vivo multiphoton imaging, mice were
sacrificed and their brains were processed for postmortem
immunohistochemical analyses. We produced coronal
sections of the entire forebrain and first analyzed a subset
of these sections spanning anteromedial extrastriate visual
cortex (VISam) and CA1 field of the hippocampus (at the
level of approx. -2.5 mm from Bregma along the rostro-
caudal axis according to [18]). These regions were selected
for in-depth analysis because the former was the principal
visual area exhibiting Arc response to this type of stimula-
tion [10] and was examined in vivo. The latter is known to
upregulate Arc following exposure to a novel environment
[19,20] and was shown to have deficits in Arc mRNA ex-
pression in the rTg4510 mouse model [21]. The sections
were immunolabelled with anti-NeuN antibodies and
treated with a red-spectrum fluorescent dye, thiazine red,
which has high affinity for beta-pleated fibrillar structures
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observed directly (Figure 2a,b). Using stereological quanti-
fication we found no difference in percentage of neurons
with NFTs between all NeuN-labeled neurons, dVenus-
positive and dVenus-negative neurons in either layer
II/III of VISam (P = 0.96, Figure 2c) or pyramidal layer of
CA1 (P = 0.84, Figure 2d). In accord with the lack of dif-
ference in stereological counts of dVenus positive re-
sponsive neurons with tangles, statistical analysis of oddsFigure 1 In vivo quantification of Arc::dVenus reporter in the visual c
stimulation paradigm described previously in [10] was followed by cranial w
imaging on a multiphoton microscope. After the imaging, the brains were
maximum intensity projections of in vivo-acquired multiphoton z-stacks fro
Arc::dVenus reporter (shown in green) expression induced by the visual stim
activity-induced Arc::dVenus fluorescence in individual visual cortex neuron
(n = 5 mice, 1043 neurons). AU, arbitrary units. n.s., not significant, P = 0.27.
same visual cortex site from an rTg4510 mouse before (left) and after (righ
Fluorescent angiogram (blue) was used as a landmark pattern during the im
NFT and the inset shows a close-up view of this neuron. Scale bar = 100 μm
activity-induced Arc::dVenus fluorescence in rTg4510 neurons without tang
neurons). AU, arbitrary units. n.s., not significant, P = 0.083.ratio for NFTs affecting probability of Arc::dVenus expres-
sion in individual host neurons was not significantly dif-
ferent from 1 (VISam: P = 0.89, Figure 2e; CA1: P = 0.17,
Figure 2f).
Tau pathology does not affect brain-wide Arc responses
Arc can be expressed in excitatory neurons in various
neuronal circuits in response to relevant sensory and be-
havioral inputs [24-26]. In order to assess the effects ofortex of rTg4510 mice. (a) Experiment outline. Structural visual
indow implantation over the medial extrastriate visual cortex and
collected and processed for immunohistochemical analysis. (b) Sample
m the layer II/III of the medial extrastriate visual cortex, showing
ulation. Scale bar = 100 μm. (c) Frequency distribution histograms of
s of rTg4510 mice (n = 8 mice, 2212 neurons) and control littermates
(d) Sample single-section in vivo multichannel micrographs of the
t) the intravenous delivery of a tangle-binding dye methoxy-X04 (red).
age analysis. Arrowheads points to a dVenus-positive neuron with an
. Inset size = 20 × 20 μm. (e) Frequency distribution histograms of
les (n = 4 mice, 720 neurons) and with tangles (n = 4 mice, 101
Figure 2 Postmortem analysis of Arc response probability in cortical and hippocampal neurons with and without NFTs. (a, b)
Immunohistochemical staining of medial extrastriate visual cortex (a) and CA1 field of the hippocampus (b) of an rTg4510 mouse. NeuN
immunolabeling is shown in cyan, direct dVenus fluorescence in green and thiazine red labeling of tangles in red. Scale bar = 25 μm.
Arrowheads in a and b point to Arc::dVenus-positive neurons with tangles. (c, d) Stereological estimations of the percentage of neurons
with tangles based on counts of NeuN-, dVenus- and thiazine red-positive neurons in the medial extrastriate visual cortex (c) and CA1
(d). Data presented as means ± s.e.m.; n.s., not significant, P = 0.96 in c, P = 0.84 in d. N = 4 mice, 4273 neurons (visual cortex) and 441
neurons (CA1). (e,f) Forest plot of odds ratios (ORs) of NFTs affecting neuronal Arc responses in extrastriate medial visual cortex (e) and
CA1 field of the hippocampus (f). Presented data were acquired from the analysis of stereological counting of neurons using Fisher’s
exact test and shown as OR ± 95% confidence interval on a log10 scale.
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level we analyzed the sets of coronal sections spanning the
entire forebrain (from 2 mm to −4.5 mm from Bregma
along the rostro-caudal axis according to [18]) with
500 μm interval. Sections were labeled with thiazine
red to visualize NFTs and DAPI, and imaged on a three-
channel setup, including a yellow filter set to detect direct
dVenus fluorescence. We identified 8 distinct areas that
had a significant number of the Arc::dVenus-positive neu-
rons in all examined mice, both transgenic and controllittermates (Figure 3). Among these areas were visual
(VISp VI, VISam II/III, auditory (AUD IV and II/III)
and piriform (PIR II, III) cortices, pyramidal layer of
CA1 field of the hippocampus and two frontal sub-
cortical association areas: claustrum (CLA) and dorsal
endopiriform nucleus (EPd). Certain regions, such as motor,
somatosensory, anterior cingulate, entorhinal, posterior
parietal cortices and dentate gyrus of hippocampus had
Arc::dVenus-positive neurons in some, but not all, ana-
lyzed brains, without correlation to genotype (data not
Figure 3 Whole-forebrain histochemical analysis of Arc::dVenus expression. Experience-dependent dVenus expression in various forebrain
regions following structured visual stimulation and NFT labeling (Thiazine Red fluorescence) in the brains of rTg4510 mice . Scale bar = 100 μm.
dVenus intensities in individual neurons are presented as medians with interquartile ranges. N = 4 control littermates, n = 5 transgenic mice.
P-values for Arc::dVenus expression comparison between rTg4510 mice and control littermates: EPd, P = 0.80 (control: n = 293 neurons; transgenic:
419); CLA, P = 0.77 (control: n = 291 neurons; transgenic: 427); PIR, P = 0.57 (control: n = 776 neurons; transgenic; 604); CA1, P = 0.92 (control:
n = 394 neurons; transgenic: 396); VISam2/3, P = 0.08 (control: n = 1298 neurons; transgenic: 519); VISp6, P = 0.18 (control: n = 952 neurons;
transgenic: 974); AUD2/3, P = 0.65 (control: n = 1427 neurons; transgenic: 1057); AUD6, P = 0.05 (control: n = 739 neurons; transgenic: 962)).
Reference atlas image credit: Allen Institute for Brain Science, Allen Mouse Brain Atlas.
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not specific to this type of behavioral stimulation. We
found no areas with significant response in control litter-
mates that had a complete absence of response in the
same region in transgenic mice or vice versa. None of
the eight above-mentioned areas had any significantdifferences in the levels of Arc::dVenus between trans-
genic mice and control littermates (Figure 3).
Previous studies have shown that the expression of
soluble mutant tau is largely responsible for behavioral
and physiological deficits and neurotoxicity in the
rTg4510 model [14,27]. We took advantage of the fact
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be suppressed by doxycyclin treatment [14,21,27] to de-
termine whether removal of soluble mutant tau in aged
mice affects brain-wide Arc responses. A cohort of 11–
12 months old transgenic and control littermate mice re-
ceived doxycycline-supplemented diet for 6 week, after
which they underwent visual stimulation as described
above and their brains were processed for the brain-wide
Arc::dVenus expression analysis. We found no effect of
doxycycline treatment on activity-driven Arc responses in
either control or transgenic mice in none of brain regions
with consistent detectable Arc expression (Figure 4).
As an additional measure of interaction between the
NFT pathology and experience-driven Arc expression,
we examined whether quantified tangle load in different
brain regions correlated with differences in Arc expression
levels between rTg4510 mice and control littermates. In
fact, we found no significant correlation between NFT
load expressed as percentage of brain area section occu-
pied by tangles and experience-driven differential Arc
expression expressed as mean log Arc expression dif-
ference between transgenic mice and control litter-
mates (Figure 5).
Discussion
This study aimed to elucidate the effects of tau path-
ology on experience-dependent neuroplasticity in indi-
vidual neurons and local neuronal networks. We applied
an experimental paradigm that we have recently devel-
oped to address a similar question in the context of Aβ
pathology [10]. Reporter mice expressing a fluorescent pro-
tein under the control of the plasticity-related immediate-
early gene Arc promoter [15] were crossed to a model of
tauopathy based on P301L mutation in the human tau
protein [14]. We studied experience-induced Arc reporterFigure 4 Effects of suppression of mutant tau expression on Arc::dVe
rTg4510 mice and control littermates is presented as medians with interqu
Arc::dVenus responses were observed in either transgenic or control mice,
for untreated control littermate and transgenic mice are as indicated in Fig
group are as following: n = 5 control littermates, 3 transgenic mice; EPd: co
transgenic: 272; PIR: control: n = 1091 neurons, transgenic: 527; CA1: contro
transgenic: 729; VISp6: control: n = 730 neurons, transgenic: 534; AUD2/3: c
neurons, transgenic: 736.expression in the brains of these mice with a combination
of in vivo longitudinal multiphoton imaging and postmor-
tem immunohistochemical analysis. Using quantitative
in vivo measurements of Arc transcription reporter followed
by detection of NFTs in large volumes of the visual cortex
of a living mouse brain, we showed that tangles did not
affect the absolute Arc expression levels in the individual
responses of neurons. At the same time, neurons with
NFTs were as likely to have Arc responses as neurons
without NFTs, as determined postmortem in the same
brain area. Similar to visual cortex neurons, CA1 pyrami-
dals with NFTs had the same likelihood of Arc responses
as their neighbors without tangles. Taking into account
the complex postsynaptic signaling and transcriptional
machinery required for the activity-driven expression of
the Arc gene [7,8,28-30], this demonstrates, for the first
time, that despite being large cytoplasmic space-occupying
inclusions, NFTs do not significantly disrupt the integra-
tion of synaptic inputs and the downstream execution of
memory-related genetic programs. The data also do not
demonstrate any changes in Arc responses to a sensory
stimulus due to the soluble mutant tau ubiquitously
expressed in the CamKII-positive neurons in this mouse
model. There is a possibility that NFTs or tau indeed intro-
duce changes to Arc responses small enough that they
could not be detected with our imaging and analysis
methods. However, in our previous study using this quanti-
fication technique with similar cohort sizes (and thousands
of neurons examined) [10] we were able to resolve signifi-
cant changes as small as 15% of median expression level
postmortem and 25% in vivo. It is unlikely that if smaller
undetected changes were induced by NFTs, they would
have significant effect on neuronal circuit function, as
these changes would be orders of magnitude lower
than Arc responses to physiological stimuli [10,11]. Thesenus responses. Arc::dVenus expression in different brain regions of
artile ranges. No significant effect of doxycycline treatment on
when corrected for multiple testings. Numbers of mice and neurons
ure 3 legend. Numbers of mice and neurons for doxycycline-treated
ntrol: n = 449 neurons, transgenic: 267; CLA: control: n = 480 neurons,
l: n = 479 neurons, transgenic: 196; VISam2/3: control: n = 1060 neurons,
ontrol: n = 1394 neurons, transgenic: 1098; AUD6: control: n = 697
Figure 5 NFT load does not correlate with the differences in Arc expression between rTg4510 and control mice. Surface area occupied
by tangles (presented as means ± s.e.m. on log10 scale for clarity) in the forebrain regions with significant Arc expression (presented in Figure 3)
in rTg4510 mice plotted versus mean (±s.e.m.) log Arc::dVenus expression difference between control and rTg4510 mice. Spearman R = 0.13, P =
0.75. N = 4 control littermates, 4 transgenic mice.
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boratory showing intact function of tangle-bearing and
tangle-free neurons in the visual cortex of rTg4510 mice
as demonstrated by in vivo multiphoton imaging of visual
activity-evoked calcium transients [31].
Our findings of unchanged Arc transcription in the vis-
ual cortex contrasted with a previous study from our la-
boratory showing decreased Arc expression in the CA1
pyramidal layer of the hippocampus in the rTg4510 model
mice after exploration of a novel environment [21] and
with the earlier mRNA profiling of the human AD brains
which found lower amounts of the Arc mRNA in tangle-
bearing CA1 neurons compared to tangle-free neurons
[32]. To gain a “brain-wide” perspective on the tau path-
ology effect on neuronal networks, we processed entire
brains of rTg4510 mice crossed with Arc reporter strain to
identify anatomical regions with detectable Arc expression
following the exposure of the mice to the structured visual
stimulation. We found no regions that lacked activation in
one genotype and were active in the other and vice versa,
which indicates that the widespread tau pathology does
not fundamentally change brain wiring patterns. We also
detected no overt differences in experience-dependent
network-wide Arc expression levels between transgenic
mice and control littermates in any of the examined brain
regions. Even the brain areas with the highest tangle load
(such as CA1 field of the hippocampus where more than
50% of the brain section was occupied by tangles) exhib-
ited normal Arc responses to the visual stimulation.
We considered the differences in experimental paradigm
between the initial study of hippocampal responses to
exploration of a novel environment [21] and the current
study, which focused on visual cortical responses to de-
fined visual stimuli. Since the retina and lateral geniculate
are disease free in this model, the latter stimulus wasdesigned to specifically probe somatodendritic responses
and integration of signals in which the axons carrying the
primary input are intact, while the behavioral/memory
aspects of the exploratory behavior task requires inte-
gration of widely dispersed information in the cortex and
concurrent signaling to the hippocampus for further pro-
cessing from areas that are markedly impacted by both
NFT and neuronal loss. It may be that this latter form of
integrative function is more dependent on the integrity of
axonal processes and on the relative timing and intensity
of feedforward and feedback signals, and so Arc reporting
of signal in the hippocampus is inherently more sensitive
to subtle effects compared to visual cortical responses.
Nonetheless, the agreement between the studies that the
presence of NFT does not impact the likelihood of an
Arc response, despite the substantially different behav-
ioral paradigms and the method of assessing Arc (in situ
hybridization v.s. Arc promoter-driven fluorescent re-
porter) emphasizes that the type of defect in signal inte-
gration caused by a tangle, if any, is quite subtle.
Overall, our findings show that NFTs do not signifi-
cantly alter postsynaptic function of the host neurons
which is required for the experience-dependent Arc ex-
pression. Given the importance of meticulous Arc regula-
tion for the proper functioning of synaptic machinery
[33-36] and the role that activity-dependent Arc expres-
sion plays in memory-related physiology through AMPAR
endocytosis [35], structural plasticity [37] and synaptic
tagging [38], our data suggest that mechanisms not linked
to experience-dependent immediate early genes are be-
hind behavioral phenotypes in rTg4510 mice and cognitive
impairment in AD. A number of studies have demon-
strated electrophysiological, functional and morphological
changes in neurons from rTg4510 mice at the advanced
stage of tau pathology [28,39-42], and, notably, increased
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indicating that these changes could not be attributed to
the presence or absence of NFTs in the affected neu-
rons [40,42]. Taken together with our data, NFTs appear
not to cause major disruptions of synaptic integration of
information.
Materials and methods
Mice
All animal experimentation was performed in conformance
with institutional and US National Institutes of Health
guidelines and approved by the Massachusetts General
Hospital Institutional Animal Care and Use Committee.
Arc::dVenus reporter mice expressing destabilized variant
of a bright yellow fluorescent protein dVenus under 7.1 kb
mouse Arc promoter [15] were crossed with suppressible
CamKII::rtTA × tetO::Tau (P301L) (rTg4510) strain [14].
Arc::dVenus × CamKII::rtTA non-carriers of Tau (P301L)
transgene were used as littermate controls to account for
potential effects of rtTA transactivator overexpression.
Genotyping was performed using polymerase chain reac-
tion (PCR) with three pairs of primers targeting dVenus,
rtTA and Tau (P301L). For mutant tau suppression experi-
ment, a cohort of mice (n = 5 control, n = 3 transgenic)
was fed chow containing 200 mg/kg doxycycline (Harlan
Teklad) for 6 weeks before visual stimulation. All mice
used in this study were 11–13 months old.
Visual stimulation, surgery and in vivo multiphoton
imaging
Structured visual stimulation was performed as described
previously [10]. Briefly, single-housed mice were placed in
their home cages into the dark light-proof ventilated en-
closures for 60 hours prior to beginning of stimulation to
suppress visual experience-induced Arc::dVenus expres-
sion. After the end of light deprivation mice were trans-
ferred to an illuminated glass cylinder with alternating
vertical black and white stripes for 1 hour. Following the
end of the visual stimulation, mice were placed back into
the home cages and put into light deprivation chambers
for 5 hours before the anesthesia for cranial window im-
plantation was induced with 4% isoflurane in balanced
oxygen inside of the dark light-proof enclosure for
5 minutes and maintained at the level of 1.2–1.6% during
the surgery and consequent imaging while keeping the
body temperature at 37°C. Cranial windows were im-
planted over the right visual cortex as described previously
[10,43]. Immediately after cranial window implantation
Texas Red-conjugated dextran (MW 70,000 Da, 12.5 mg/
mL in sterile PBS, Molecular Probes) was injected IV to
provide fluorescent angiogram used as landmark pattern
for co-registration of two consecutive imaging sessions
and as a reference fluorophore to monitor cranial window
clarity and appearance of bleedings. Mice were imaged onmultiphoton Olympus Fluoview 1000 MPE system equipped
with mode-locked titanium/sapphire MaiTai laser (Spectra-
Physics) and Olympus BX61WI upright microscope with
XLPLN 25× water-immersion objective (NA = 1.05). Z-
stacks in both imaging sessions were acquired with the
resolution of 1 μm/pixel in X-Y dimension with the Z-step
of 3 μm. For each mouse the imaged site consisted of 2×4
512×512×240 μm stacks acquired with 10% overlap in
X–Y dimensions resulting in an imaged field in visual
cortex spanning roughly 1×2×0.24 mm3 ((m–l) × (r–c) ×
(d–v)). For the first imaging session, excitation laser was
tuned to 860 nm with the output power set to 76 mW
before the objective. Emitted light was collected in three
channels: 460–500 nm (autofluorescence), 530–560 nm
(dVenus fluorescence) and 575–630 nm (Texas Red
dextran angiogram). Then, methoxy-X04 (5 mg/kg) [44]
diluted in Texas Red dextran solution (12.5 mg/mL in
sterile PBS) was injected IV to label NFTs. 30 minutes
after methoxy-X04 injection, a second imaging of the
same site was performed with the excitation laser tuned to
800 nm for more efficient detection of metoxy-X04 fluor-
escence, with 100 mW output power before the objective.
In this session, the 460–500 nm channel collected emitted
light from methoxy-X04 bound to the tangles and other
two channels contained the same dVenus and Texas Red
dextran signals as in the first sessions and were used for
consequent co-registration of the two image stacks. Im-
aging settings were kept constant between mice and the
laser output power was calibrated before each imaging
session using infrared photometer.
Processing and quantification of in vivo imaging data
Only image stacks acquired during the first imaging ses-
sion (860 nm excitation, before methoxy-X04 injection)
were used for quantification of Arc::dVenus expression
levels to avoid potential spectral crosstalk with methoxy-
X04. Arc::dVenus expression levels were processed using
Fiji package of NIH ImageJ software (fiji.sc; rsbweb.nih.
gov/ij) as described previously [10]. Both stacks (before
and after methoxy-X04 injection) were aligned side-
by-side based on dVenus and Texas Red dextran pat-
terns (as on Figure 1d) and each quantified dVenus-positive
neuron was manually assigned a tangle-positive or tangle-
negative status.
Post-mortem tissue analysis
After the end of in vivo imaging still anesthetized mice
were transcardially perfused with ice-cold phosphate-
buffered saline (PBS) followed by 4% paraformaldehyde
in PBS. Brains were incubated in fixative at 4°C for
48 hours and 50 μm free-floating sections were cut on a
Microm HM400 microtome. Coronal sections were con-
secutively collected into 10 tubes, so each tube con-
tained a set of sections covering the full forebrain with
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tions were first incubated in thiazine red (MP Biomedicals,
0.01% in PBS) for 20 min to label NTFs and washed 3
times with PBS, followed by immunolabeling with mouse
anti-NeuN antibody (1:500, Cat. No MAB377, Millipore)
and secondary goat-anti-mouse AlexaFluor 350 (1:500,
Cat. No A11045, Molecular Probes). Stereological count-
ing of Arc::dVenus- and NeuN-positive neurons was per-
formed on Olympus CAST system in neuronal layer II/III
of medial extrastriate visual cortex and pyramidal layer of
CA1 field of the hippocampus. Images for Figure 2 were
acquired on Zeiss Axio Observer. Z1 fluorescent micro-
scope equipped with 40× objective. For the full-brain ana-
lysis, an entire set of sections spaced at 500 μm from each
mouse was labeled with thiazine red mixed with DAPI
(0.2 μg/ml), washed for 1 hour in 1% Triton-X100 in PBS
and 3 times in PBS. Full-section tile scan was performed
on Zeiss Axio Observer. Z1 microscope with 5× objective
run by MetaMorph (Molecular Devices) using following
three filter sets: Ex/Em 365/445 nm (DAPI), 500/545 nm
(direct dVenus fluorescence) and 545/620 (thiazine red).
Stitched multichannel images were manually aligned to
Allen Mouse Brain Reference atlas (brain-map.org). All
image processing was performed in Fiji package of ImageJ.
To quantify Arc::dVenus in individual cells, regions of
interest with Arc::dVenus-positive neurons in the dVenus
channel were cropped to save computation time, back-
ground subtracted, images thresholded and segmented
with “Analyze particles” plug-in to identify cell bodies. The
cell body masks were then applied to the pre-thresholded
images to measure mean fluorescence intensity in each
identified cell body. To quantify NFT load, brain regions of
interest were outlined based on reference atlas alignment
and DAPI labeling. Crop masks were applied to the thia-
zine red channel, images thresholded and percentage of
area occupied by tangles calculated.
Statistical analysis
The normality of all datasets was tested using Kolmogorov-
Smirnov method. Non-normal datasets of Arc::dVenus
expression levels in individual neurons with variable sam-
ple sizes (Figure 1 and 3) were compared using Wilcoxon
rank-sum test with correction for clustering of values
within individual mice [45]. Comparison of normal data
with identical sample sizes (Figure 2c,d) was performed
using one-way ANOVA with Bonferroni post-test. The
associations between tangles and Arc responses and cor-
responding odds ratios (Figure 2) were analyzed using
2-way contingency table analysis with Fisher’s exact test
(GraphPad Prism 5); this assumes independence across
neurons. To assess the effects of doxycycline treatment
(Figure 4) we used a mixed effects model to adjust for treat-
ment and genotype and their interaction, with adjustment
for correlation within mouse. Each region was modeledseparately. We corrected for multiple testing across the
eight brain regions using a Bonferroni correction. Calcula-
tion of Spearman R and correlation P-value for normal
tangle load data with identical sample sizes (Figure 5) was
performed on average values across mice.
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